Measurement of multiple value of medical innovation and application to design of drug price and cost burden
| Project/Area Number |
25705008
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (A)
|
| Allocation Type | Partial Multi-year Fund |
|---|
| Research Field |
Public finance/Public economy
|
|---|
| Research Institution | Chiba University |
|---|
Principal Investigator |
Nagane Hiromi 千葉大学, 大学院社会科学研究院, 准教授 (60447597)
|
|---|
| Project Period (FY) |
2013-04-01 – 2018-03-31
|
| Project Status |
Completed (Fiscal Year 2017)
|
| Budget Amount *help |
¥9,880,000 (Direct Cost: ¥7,600,000、Indirect Cost: ¥2,280,000)
Fiscal Year 2016: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2015: ¥3,510,000 (Direct Cost: ¥2,700,000、Indirect Cost: ¥810,000)
Fiscal Year 2014: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2013: ¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
|
|---|
| Keywords | イノベーション / 大学・公的研究機関 / 基礎研究 / 医薬品 / 医療保険制度 / バイオ医薬品 / 医師 / パイプライン / 産学官連携 / 科学技術 |
|---|
| Outline of Final Research Achievements |
This research has a motivation on how to create new medical technology and how to disseminate it. Therefore, this research focuses on medical drugs according to an axis from creation of innovative medical technology to access to them. This research's main purposes;(1) to measure consistently value of medical innovation from multiple views. (2)to show how we should set drug price to give pharmaceutical firms R&D incentives and patient's cost burden, (3)to show what health insurance system to deal consistently value of medical innovation.
|
Report
(6 results)
Research Products
(33 results)
